Incyte (INCY) EBIT Margin (2009 - 2026)
Incyte (INCY) recorded EBIT Margin of -45.49% in Q3 2026, down 77.96 percentage points from 32.47% a year earlier and down 87.18 percentage points from the prior quarter.
Powered by 
Analysis
Incyte (INCY) EBIT Margin (2009 - 2026) Analysis & Trends
On a TTM basis, Incyte's EBIT Margin came in at 10.42% as of Sep 30, 2026, down 20.34 percentage points year-over-year; for FY2025, it was 29.46%, up 28.02 percentage points from FY2024.
- Annual EBIT Margin has a five-year change of +39.35 percentage points (FY2020 to FY2025).
- Across earlier years, EBIT Margin came in at 1.45% in FY2024 (-15.34 pp), 16.79% in FY2023 (-0.28 pp), 17.07% in FY2022 (-2.55 pp) and 19.62% in FY2021 (+29.50 pp).
- The Q3 2026 figure is the lowest quarterly EBIT Margin since Q2 2024.
- On a year-over-year basis, EBIT Margin rose in five of the last eight quarters, with an average year-over-year change of +5.78 percentage points.
- Peak year-over-year performance for EBIT Margin in the last five years was a gain of 89.44 percentage points in Q2 2025, against a drop of 77.96 percentage points in Q3 2026 at the low end.
- Per Business Quant, the preceding three quarters came in at 41.69% (Q2 2026), 23.66% (Q1 2026) and 22.29% (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 34.46% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 24.35% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 36.01% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 30.74% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 29.12% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 35.79% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 41.71% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 32.98% |
| 10 | Incyte | 245.42 Mn | -15.74 Bn | 1.45 Bn | -45.49% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -45.49% |
| Jun 30, 2026 | 41.69% |
| Mar 31, 2026 | 23.66% |
| Dec 31, 2025 | 22.29% |
| Sep 30, 2025 | 32.47% |
| Jun 30, 2025 | 43.63% |
| Mar 31, 2025 | 19.49% |
| Dec 31, 2024 | 25.58% |
| Sep 30, 2024 | 12.84% |
| Jun 30, 2024 | -45.81% |
| Mar 31, 2024 | 10.43% |
| Dec 31, 2023 | 18.48% |
| Sep 30, 2023 | 23.36% |
| Jun 30, 2023 | 20.30% |
| Mar 31, 2023 | 3.06% |
| Dec 31, 2022 | 7.56% |
| Sep 30, 2022 | 16.81% |
| Jun 30, 2022 | 27.92% |
| Mar 31, 2022 | 15.89% |
| Dec 31, 2021 | 12.83% |
API Access
Incyte EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=INCY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "INCY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=INCY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();